← Leaderboards
Ta-Yuan Chang
Dartmouth College
$17,233,174
Attributed
$17,233,174
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$17,233,174 · 7
By mechanism
R01$15,019,799 · 4
R37$1,415,013 · 1
R21$798,362 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cholesterol”
- Leon J Thal · University Of California San Diego$54,467,813
- Daniel James Rader · University Of Pennsylvania$44,733,174
- Alan Richard Tall · Columbia University Health Sciences$38,760,184
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$38,718,698
- Ronald M Krauss · University Of Calif-Lawrenc Berkeley Lab$34,107,220
- Stanley L Hazen · Cleveland Clinic Foundation$28,886,562
Research focus
CholesterolAlzheimer&AposEndoplasmic ReticulumCholesterol EstersSterol O-AcyltransferaseCellsS DiseaseEnzymesSterol O-Acyltransferase 1PlayProteinsMembraneBrainAtherosclerosisMediatingAcyl Coenzyme ASterolsApolipoprotein EInhibitor/AntagonistNeuronsCell MembraneCholesterol HomeostasisEsterificationNeurodegenerative Disorders
Grant awards (50)
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage$410,000
R01 · FY2021 · AG · contact PI
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage$410,000
R01 · FY2020 · AG · contact PI
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage$408,373
R01 · FY2020 · AG · contact PI
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage$410,000
R01 · FY2019 · AG · contact PI
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease$332,100
R01 · FY2019 · AG · contact PI
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage$247,640
R01 · FY2019 · AG · contact PI
Alleviating lysosomal lipid defects in ADRD by blocking cholesterol storage$410,000
R01 · FY2018 · AG · contact PI
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease$332,100
R01 · FY2018 · AG · contact PI
Rescuing the ApoE4 genotype by activating sterol biosynthesis in the CNS$205,501
R21 · FY2018 · AG · contact PI
Impact of microglial cholesterol storage on neuroinflammation$102,915
R01 · FY2018 · AG · contact PI
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease$332,100
R01 · FY2017 · AG · contact PI
Rescuing the ApoE4 genotype by activating sterol biosynthesis in the CNS$186,751
R21 · FY2017 · AG · contact PI
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease$332,100
R01 · FY2016 · AG · contact PI
Functional Analysis of ACAT$398,925
R01 · FY2015 · HL · contact PI
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease$332,100
R01 · FY2015 · AG · contact PI
Functional Analysis of ACAT$444,376
R01 · FY2014 · HL · contact PI
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease$311,333
R01 · FY2014 · AG · contact PI
Functional Analysis of ACAT$390,320
R01 · FY2013 · HL · contact PI
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease$294,209
R01 · FY2013 · AG · contact PI
Functional Analysis of ACAT$90,580
R01 · FY2013 · HL · contact PI
Cell Mutants Defective in Cholesterol Ester Formation$451,349
R01 · FY2012 · HL · contact PI
Functional Analysis of ACAT$395,000
R01 · FY2012 · HL · contact PI
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease$311,333
R01 · FY2012 · AG · contact PI
Cell Mutants Defective in Cholesterol Ester Formation$451,349
R01 · FY2011 · HL · contact PI
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease$311,333
R01 · FY2011 · AG · contact PI
Cell Mutants Defective in Cholesterol Ester Formation$455,907
R01 · FY2010 · HL · contact PI
Functional Analysis of ACAT$395,546
R01 · FY2010 · HL · contact PI
Cholesterol and Sphingolipid Metabolism in Alzheimer's Disease$323,900
R01 · FY2010 · AG · contact PI
Cell Mutants Defective in Cholesterol Ester Formation$450,529
R01 · FY2009 · HL · contact PI
Functional Analysis of ACAT$384,025
R01 · FY2009 · HL · contact PI
Cell Mutants Defective in Cholesterol Ester Formation$436,313
R01 · FY2008 · HL · contact PI
Functional Analysis of ACAT$372,840
R01 · FY2008 · HL · contact PI
Cell Mutants Defective in Cholesterol Ester Formation$422,282
R01 · FY2007 · HL · contact PI
Functional Analysis of ACAT$361,982
R01 · FY2007 · HL · contact PI
Cell Mutants Defective in Cholesterol Ester Formation$422,224
R01 · FY2006 · HL · contact PI
FUNCTION ANALYSIS OF HUMAN ACAT$347,147
R01 · FY2006 · HL · contact PI
Cell Mutants Defective in Cholesterol Ester Formation$419,796
R01 · FY2005 · HL
FUNCTION ANALYSIS OF HUMAN ACAT$355,500
R01 · FY2005 · HL
Attenuating sterol synthesis in WT and NPC mice brains$221,804
R21 · FY2005 · NS
Cell Mutants Defective in Cholesterol Ester Formation$407,565
R01 · FY2004 · HL
STRUCTURE/FUNCTION ANALYSIS OF ACAT$355,500
R01 · FY2004 · HL
Attenuating sterol synthesis in WT and NPC mice brains$184,306
R21 · FY2004 · NS
CELL MUTANTS DEFECTIVE IN CHOLESTEROL ESTER FORAMTION$369,588
R37 · FY2003 · HL
STRUCTURE/FUNCTION ANALYSIS OF ACAT$355,500
R01 · FY2003 · HL
CELL MUTANTS DEFECTIVE IN CHOLESTEROL ESTER FORAMTION$358,823
R37 · FY2002 · HL
STRUCTURE/FUNCTION ANALYSIS OF ACAT$289,587
R01 · FY2002 · HL
CELL MUTANTS DEFECTIVE IN CHOLESTEROL ESTER FORAMTION$348,374
R37 · FY2001 · HL
STRUCTURE/FUNCTION ANALYSIS OF ACAT$281,155
R01 · FY2001 · HL
CELL MUTANTS DEFECTIVE IN CHOLESTEROL ESTER FORAMTION$338,228
R37 · FY2000 · HL
STRUCTURE/FUNCTION ANALYSIS OF ACAT$272,966
R01 · FY2000 · HL